Gene coding for heliomicine and use thereof
US6916782B1 · kind B1 · utility
6Cited by
2References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 1999 |
| Grant date | Jul 12, 2005 |
| Priority date | — |
| Expiry date | Apr 12, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns heliomicine, A DNA sequence coding for heliomicine, a vector containing it for transfroming a host organism and the transformation method. The invention concerns heliomicine as a medicine in particular for treating fungal infections. More particularly, it concerns the transformation of plant cells and plants, the heliomicine produced by the transformed plants ensuring their resistance to diseases, in particular diseases of fungal origin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.